Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 53746-845

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 53746-845). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Valsartan And Hydrochlorothiazide Tablets Usp 1)

Figure 1 (Valsartan And Hydrochlorothiazide Tablets Usp 1)
A line graph depicting the percentage of subjects with systolic blood pressure (SBP) below 140 mmHg plotted against baseline SBP values ranging from 140 to 180 mmHg. Four lines compare results for Valsartan and Hydrochlorothiazide 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo.*
FDA Label Image

320 mg/12.5 mg Label (Valsartan And Hydrochlorothiazide Tablets Usp 10)

320 mg/12.5 mg Label (Valsartan And Hydrochlorothiazide Tablets Usp 10)
Label for Valsartan and Hydrochlorothiazide 320 mg/12.5 mg film-coated tablets, distributed by Amneal Pharmaceuticals LLC. The label includes the NDC 53746-848-90 and depicts a small, oblong film-coated tablet imprinted with '848'. It states the package contains 90 tablets for prescription use only and includes storage instructions and distributor information.*
FDA Label Image

320 mg/25 mg Label (Valsartan And Hydrochlorothiazide Tablets Usp 11)

320 mg/25 mg Label (Valsartan And Hydrochlorothiazide Tablets Usp 11)
Label for Valsartan and Hydrochlorothiazide Tablets, USP 320 mg/25 mg, film-coated oral tablets. The label indicates a package of 90 tablets, Rx only, distributed by Amneal Pharmaceuticals LLC. The tablet is oval, light orange, and imprinted with '849'. Storage instructions and bar code are also visible.*
FDA Label Image

Figure 2 (Valsartan And Hydrochlorothiazide Tablets Usp 2)

Figure 2 (Valsartan And Hydrochlorothiazide Tablets Usp 2)
A line graph comparing the percentage of DBP-90 (mmHg) reduction versus baseline DBP (mmHg) for Valsartan and Hydrochlorothiazide 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo. The graph shows distinct curves for each treatment group across baseline DBP values from 90 to 110 mmHg.*
FDA Label Image

Figure 3 (Valsartan And Hydrochlorothiazide Tablets Usp 3)

Figure 3 (Valsartan And Hydrochlorothiazide Tablets Usp 3)
A line chart depicting the percentage of subjects achieving systolic blood pressure (SBP) under 130 mmHg across baseline SBP values ranging from 140 to 180 mmHg. The chart compares four groups: Valsartan and Hydrochlorothiazide 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo, showing the relative efficacy of each treatment.*
FDA Label Image

Figure 4 (Valsartan And Hydrochlorothiazide Tablets Usp 4)

Figure 4 (Valsartan And Hydrochlorothiazide Tablets Usp 4)
A line chart comparing the percentage of diastolic blood pressure below 80 mmHg (% DBP <80) relative to baseline diastolic blood pressure (DBP in mmHg) from 90 to 110 mmHg. Four treatments are represented: Valsartan and Hydrochlorothiazide 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo, differentiated by distinct markers.*
FDA Label Image

Valsartan Structural Formula (Valsartan And Hydrochlorothiazide Tablets Usp 5)

Valsartan Structural Formula (Valsartan And Hydrochlorothiazide Tablets Usp 5)
Chemical structure diagram of the active ingredient Valsartan, showing its molecular bonds and components.*
FDA Label Image

Hydrochlorothiazide Structural Formula (Valsartan And Hydrochlorothiazide Tablets Usp 6)

Hydrochlorothiazide Structural Formula (Valsartan And Hydrochlorothiazide Tablets Usp 6)
Chemical structure of valsartan depicted as a molecular diagram showing functional groups including a sulfonamide and chloro-substituted aromatic ring.*
FDA Label Image

80 mg/12.5 mg Label (Valsartan And Hydrochlorothiazide Tablets Usp 7)

80 mg/12.5 mg Label (Valsartan And Hydrochlorothiazide Tablets Usp 7)
Label for Valsartan and Hydrochlorothiazide Tablets USP 80 mg/12.5 mg film-coated tablets, containing 90 tablets for oral use. Distributed by Amneal Pharmaceuticals LLC. The label includes storage instructions, a barcode, and the pill imprint '845' in orange on a pink tablet image.*
FDA Label Image

160 mg/12.5 mg Label (Valsartan And Hydrochlorothiazide Tablets Usp 8)

160 mg/12.5 mg Label (Valsartan And Hydrochlorothiazide Tablets Usp 8)
Label for Valsartan and Hydrochlorothiazide 160 mg / 12.5 mg film-coated tablets distributed by Amneal Pharmaceuticals LLC. The label indicates 90 tablets per container, prescription use only, and provides storage instructions, dosage content, and a barcode. The Amneal logo is displayed on the lower left side.*
FDA Label Image

160 mg/25 mg Label (Valsartan And Hydrochlorothiazide Tablets Usp 9)

160 mg/25 mg Label (Valsartan And Hydrochlorothiazide Tablets Usp 9)
Label for Valsartan and Hydrochlorothiazide tablets, USP 160 mg/25 mg, film-coated oral tablets. The label shows the product name, strength, and indicates a package size of 90 tablets. Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ. Storage instructions and a barcode are also visible, along with an image of an oblong brown tablet imprinted with '847'.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.